Mycoplasma and Infectious Coryza Vaccine, Inactivated
- Indication / Application: For the prevention of chronic respiratory disease caused by Mycoplasma gallisepticum and infectious coryza caused by Avibacterium paragallinarum serotypes A, B, and C.
- Manufacturing: Produced in GMP-certified facility
- Supply Mode: Bulk Supply / Distributor / OEM Available
- Origin: China
Generic Name
Mycoplasma and Infectious Coryza Vaccine, Inactivated
Composition and Content
| Disease | Strain/Serotype | Antigen Content |
|---|---|---|
| MG | MG(CR) | ≥ 109 CCU/ml |
| MS(WH) | ≥ 109 CCU/ml | |
| IC | A | ≥ 6.0 × 108 CFU/ml |
| B | ≥ 10.0 × 108 CFU/ml | |
| C | ≥ 8.0 × 108 CFU/ml |
Indications
For the prevention of chronic respiratory disease caused by Mycoplasma gallisepticum and infectious coryza caused by Avibacterium paragallinarum serotypes A, B, and C. Immunity develops within 28 days and lasts for 4 months.
Dosage and Administration
Administer subcutaneously in the neck or intramuscularly in the breast to chickens 4 weeks of age or older at 0.5 mL per bird.
Adverse Reactions
Generally, no adverse reactions occur.
Specification
250 mL/bottle; 500 mL/bottle.
Storage and Shelf Life
Store at 2-8°C. Shelf life: 24 months.
Appearance
A uniform milky-white emulsion.
Precautions
- 1. This product is for vaccination of healthy chickens only.
- 2. Sterilize syringes and replace needles promptly during vaccination.
- 3. Do not freeze or heat this product.
- 4. Allow the vaccine to reach room temperature and shake thoroughly before use.
- 5. Use the vaccine on the day the vial is opened.
- 6. Do not use within 28 days before slaughter.